AzTrials
AzTrials

Gambling DisorderPASSNCT05413564

Impact of a Self-Exclusion Procedure Optimized by an Extension of the Suspension of Commercial Solicitations

A study testing optimized self-exclusion procedure by extending the suspension of commercial solicitations for a total of 9 months in people with Gambling Disorder, run by Centre Hospitalier Universitaire de Nīmes at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Considering that self-exclusion from gambling on a particular website is an intervention for and by individuals who have developed a gambling disorder, it is currently exclusively a behavioural intervention in the sense that it prevents the behaviour Resumption of commercial solicitations only in the period when… Read more about this study

Who is it for?
Ages 18 to 99 yearsHealthy volunteers can take part
Conditions the study is for
Gambling Disorder
What is being tested?
optimized self-exclusion procedure by extending the suspension of commercial solicitations for a total of 9 months
Could I receive a placebo?
No, everyone receives an active treatment
How many people
2,554 participants
Where
1 siteFrance
Study dates
30 May 2022to 1 May 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 99 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • 18 years or older
  • self-excluder during the recruitment period
  • Online sports betting
  • poker and horse racing player
  • account opened for at least 4 weeks
  • self-exclusion for 3 months or less (minimum 3 days).

Who cannot join

  • Player who has objected to the use of his collected data when opening his account.
  • It's not the first self-exclusion of the inclusion period.

Trial locations and contacts

1 site in 1 country.

France1 site
  • Amandine LUQUIENS

    Nîmes, Nîmes, 30029

Other trials in France

About this study

Considering that self-exclusion from gambling on a particular website is an intervention for and by individuals who have developed a gambling disorder, it is currently exclusively a behavioural intervention in the sense that it prevents the behaviour Resumption of commercial solicitations only in the period when gambling is not accessible in the corresponding website , through voluntary self-exclusion (where the gambler prevents himself or herself from gambling), does not appear to be sufficient to prevent relapse. Early commercial solicitations, in the immediate intercourse after the end of the self-exlcusion period may precipitate relapse in gamblers whose behaviour change is by definition recent, and who have only received a behavioural measure. The investigators hypothesize an improved efficacy as measured by reduced gambling after a self-exclusion optimized by a period of suspension of commercial solicitations extended to 9 months, compared to self-exclusion with the standard procedure. Gamblers will be randomized according to an a priori randomization list.

Read the detailed description

This is a study evaluating the impact of PMU's implementation of an optimized self-exclusion procedure by extending the suspension of commercial solicitations for a total of 9 months, the self-exclusion being referred to as a non-medical "responsible gambling" tool, compared to the standard procedure. The self-excluded gamblers will be randomized according to an a priori randomization list, and will receive either the optimized self-exclusion procedure A or the standard self-exclusion procedure B. The study consists of a comparison between two groups A and B. The study involves non-medical gambling and socio-demographic data, routinely recorded in a regulatory manner with a permanent CNIL authorization PMU.

Being tested
optimized self-exclusion procedure by extending the suspension of commercial solicitations for a total of 9 months
Medical subject headings
Gambling

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • optimized self-exclusion procedure by extending the suspension of commercial solicitations for a total of 9 monthsOther

    optimized self-exclusion procedure A

Study groups in NCT05413564
Study groupRoleWhat they receive
optimized self-exclusion procedure AOtheroptimized self-exclusion procedure by extending the suspension of commercial solicitations for a total of 9 months
Receives: Other: optimized self-exclusion procedure by extending the suspension of commercial solicitations for a total of 9 months
standard procedureOtherstandard self-exclusion procedure B
Receives: Other: optimized self-exclusion procedure by extending the suspension of commercial solicitations for a total of 9 months

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. change in total net loss

    Evaluate the effect of the self-exclusion procedure optimized by extending the suspension of commercial solicitations for a total of 9 months, compared to the existing procedure, on the intensity of gambling.

    Measured: over the last 4 weeks,between the last 4 weeks before self-exclusion T0, and the last 4 weeks at 9 months T2

Secondary outcomes (1)
  1. change in total net loss

    Evaluate early efficacy at 6 months, maintenance of efficacy at 18 months comparison of changes according to type of play

    Measured: between last 4 weeks prior to self-exclusion, and last 4 weeks at 6 months T1, 12 months T3 and 18 months T4

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Jun 2022
  2. Study start30 May 2022
  3. Primary completion1 Nov 2022
  4. Study completion1 May 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Non-randomised
Intervention model
Factorial
Masking
None (open label)
Enrolment
2,554 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05413564
Sponsor's protocol ID
LOCAL 2021 /AL
Acronym
PASS
Status last verified
Jan 2026
First submitted
24 May 2022
Last updated
23 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • von Hammerstein C, Benyamina A, Luquiens A. Long-term efficacy of an optimized online gambling self-exclusion procedure with extended suspension of commercial solicitations: a randomized controlled trial. Harm Reduct J. 2025 Dec 30;22(1):204. doi: 10.1186/s12954-025-01339-0.

    PubMed 41469674

Questions about this trial

What is this clinical trial studying?

A study testing optimized self-exclusion procedure by extending the suspension of commercial solicitations for a total of 9 months in people with Gambling Disorder, run by Centre Hospitalier Universitaire de Nīmes at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

change in total net loss (time frame: over the last 4 weeks,between the last 4 weeks before self-exclusion T0, and the last 4 weeks at 9 months T2). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05413564, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in